Ruthenium Red - CAS 11103-72-3
Not Intended for Therapeutic Use. For research use only.
Category:
ADCs
Product Name:
Ruthenium Red
Catalog Number:
11103-72-3
CAS Number:
11103-72-3
Description:
Ruthenium red is a polycationic dye that inhibits sarcoplasmic reticulum Ca2+ release, blocks Ca2+ uptake and release from mitochondria, and prevents Ca2+ release from ryanodine-sensitive intracellular stores in skeletal and cardiac muscle.
Molecular Weight:
786.35
Molecular Formula:
Cl6H42N14O2Ru3
COA:
Inquire
MSDS:
Inquire
Tag:
ADCs Cytotoxin
Chemical Structure
CAS 11103-72-3 Ruthenium Red

Related ADCs Cytotoxin Products


Seco-DuocarmycinDMG
(CAS: 1613286-55-7)

Seco-Duocarmycin DMG is a cytotoxic agent, used as the cytotoxic component in antibody-drug conjugates.

CAS 101043-37-2 Microcystin-LR

Microcystin-LR
(CAS: 101043-37-2)

Microcystin-LR is a selective inhibitor of protein phosphatase 2A (PP2A) (IC50= 0.04 nM) and will completely inhibit this enzyme without affecting PP1 when used...

Olitoriside
(CAS: 13289-20-8)

Extrat from the seeds of Corchorus olitoriu, a cardiac Glycoside.

CAS 11094-61-4 Erabutoxin A

Erabutoxin A
(CAS: 11094-61-4)

An antagonist of the nicotinic acetylcholine receptor at the neuromuscular junction. Erabutoxin B from Laticauda semifasciata (Sea Snake)

CAS 522-11-2 Evoxine

Evoxine
(CAS: 522-11-2)

Evoxine (haploperine) is a furoquinoline alkaloid with hypnotic and sedative effects. It is found naturally in a variety of Australian and African plants includ...

ShK – Stichodactyla toxin
(CAS: 165168-50-3)

ShK (Stichodactyla helianthus Neurotoxin) has been isolated from the venom of the Carribean sea anemone Stoichactis helianthus. ShK inhibits voltage-dependent p...

Glutasam
(CAS: 148822-98-4)

Complex of lanthanide element,an anticoagulant. The lanthanide element from Glutasam replaces calcium in its complex with prothrombine, thus preventing the form...

CAS 500-56-1 Convolamine

Convolamine
(CAS: 500-56-1)

An anesthetic acting on the nerve endings, with a good selectivity on sensory nerves; lowers arterial pressure; vasodilator. Tropane alkaloid , from plants of t...

CAS 108852-90-0 Nemorubicin

Nemorubicin
(CAS: 108852-90-0)

Nemorubicin, is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity pro...

CAS 745017-94-1 MMAF

MMAF
(CAS: 745017-94-1)

Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab ma...

Q Pr

Synthetic, nicotinic AChR. Rigid bicyclic analog of TMA and TEA.

CAS 523-50-2 Angelicin

Angelicin
(CAS: 523-50-2)

Photosensitizing; used for determining DNA/RNA structures in cells and microorganisms. Furocoumarin , from plants of the Psoralea genus, Leguminosae.

3-beta-iodo-Imperialine

Cervane alkaloid derivative of Imperialine from the plant Petilium eduardi. A selective M2 muscarinic receptor antagonist.

Pentazoline hydrochloride
(CAS: 61939-12-6)

Synthetic, an inhibitor of monoamine oxydase.

CAS 4081-22-5 BOMIN-1

BOMIN-1
(CAS: 4081-22-5)

Synthetic, a selective irreversible inhibitor of carboxylesterases

CAS 18172-33-3 Cyclopiazonic Acid

Cyclopiazonic Acid
(CAS: 18172-33-3)

Cyclopiazonic acid is a mycotoxin produced by molds including certain species of Penicillium and Aspergillus. Its toxicity is linked to its ability to specifica...

CAS 74239-55-7 Methiazole

Methiazole
(CAS: 74239-55-7)

Methimazole inhibits the enzyme thyroperoxidase, which normally acts in thyroid hormone synthesis by oxidizing the anion iodide (I−) to iodine (I2), hypoiodous ...

Seco-Duocarmycin MB

Seco-Duocarmycin MB is a cytotoxic agent, used as the cytotoxic component in antibody-drug conjugates.

CAS 994-29-6 Et3N-Me

Et3N-Me
(CAS: 994-29-6)

Ganglioblocker Quaternary triethylamine derivative Synthetic

CAS 480-39-7 Pinocembrin

Pinocembrin
(CAS: 480-39-7)

Pinocembrin is a flavanoid with antioxidant activity found in damiana, honey, and propolis. Recent studies show that Pinocembrin maybe be a therapeutic option i...